Peptron Inc..

Since 1997, Peptron has developed platform technologies for peptide-based medicines. In line with proprietary technologies, we are developing sustained-release (SR) medications that extend the release profile of the drug from weekly to monthly. Smart Depot™ brings the initial research process to the final medication development and successful commercialization phase with a high technological entrance barrier and excellent product competitiveness, which enables us to expand our business and cooperate with global pharmaceutical partners.

Smart Depot technology: Sustained-release (SR) technology without modification of API to extend the release profile and ...